Rohanizah Abdul Rahim

Dr. Rohanizah Abdul Rahim


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
RRRohanizah Abdul Rahim
Rohanizah Abdul Rahim
PJPutri Ayu Jayusman
Putri Ayu Jayusman
NMNorliza Muhammad
Norliza Muhammad
NMNorazlina Mohamed
Norazlina Mohamed
VLVuanghao Lim
Vuanghao Lim
INIsa Naina-Mohamed
Isa Naina-Mohamed
Oxidative stress and inflammation are two common risk factors of various life-threatening disease pathogenesis. In recent years, medicinal plants that possess antioxidant and anti-inflammatory activities were extensively studied for their potential role in treating and preventing diseases. Spilanthes acmella (S. acmella), which has been traditionally used to treat toothache in Malaysia, contains various active metabolites responsible for its anti-inflammatory, antiseptic, and anesthetic bioactivities. These bioactivities were attributed to bioactive compounds, such as phenolic, flavonoids, and alkamides. The review focused on the summarization of in vitro and in vivo experimental reports on the antioxidant and anti-inflammatory actions of S. acmella, as well as how they contributed to potential health benefits in lowering the risk of diseases that were related to oxidative stress. The molecular mechanism of S. acmella in reducing oxidative stress and inflammatory targets, such as inducible nitric oxide synthase (iNOS), transcription factors of the nuclear factor-κB family (NF-κB), cyclooxygenase-2 (COX-2), and mitogen-activated protein kinase (MAPK) signaling pathways were discussed. Besides, the antioxidant potential of S. acmella was measured by total phenolic content (TPC), total flavonid content (TFC), 2,2-diphenyl-1-picrylhydrazyl (DPPH), and superoxide anion radical scavenging (SOD) and thiobarbituric acid reactive substance (TBARS) assays. This review revealed that S. acmella might have a potential role as a reservoir of bioactive agents contributing to the observed antioxidant, anti-inflammatory, and health beneficial effects.

RRRohanizah Abdul Rahim
Rohanizah Abdul Rahim
PJPutri Ayu Jayusman
Putri Ayu Jayusman
NMNorliza Muhammad
Norliza Muhammad
FAFairus Ahmad
Fairus Ahmad
NMNorfilza Mokhtar
Norfilza Mokhtar
ASAhmad Nazrun Shuid
Ahmad Nazrun Shuid
Plant-derived polyphenolic compounds have gained widespread recognition as remarkable nutraceuticals for the prevention and treatment of various disorders, such as cardiovascular, neurodegenerative, diabetes, osteoporosis, and neoplastic diseases. Evidence from the epidemiological studies has suggested the association between long-term consumption of diets rich in polyphenols and protection against chronic diseases. Nevertheless, the applications of these phytochemicals are limited due to its low solubility, low bioavailability, instability, and degradability by in vivo and in vitro conditions. Therefore, in recent years, newer approaches have been attempted to solve the restrictions related to their delivery system. Nanoencapsulation of phenolic compounds with biopolymeric nanoparticles could be a promising strategy for protection and effective delivery of phenolics. Poly(lactic-co-glycolic acid) (PLGA) is one of the most successfully developed biodegradable polymers that has attracted considerable attention due to its attractive properties. In this review, our main goal is to cover the relevant recent studies that explore the pharmaceutical significance and therapeutic superiority of the advance delivery systems of phenolic compounds using PLGA-based nanoparticles. A summary of the recent studies implementing encapsulation techniques applied to polyphenolic compounds from plants confirmed that nanoencapsulation with PLGA nanoparticles is a promising approach to potentialize their therapeutic activity.

18 March 2018 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
RRRohanizah Abdul Rahim
Rohanizah Abdul Rahim
Nor Hazwani AhmadNor Hazwani Ahmad
Nor Hazwani Ahmad
Khaldun Mohammad Al AzzamKhaldun Mohammad Al Azzam
Khaldun Mohammad Al Azzam
IMIshak Mat
Ishak Mat
Purpose: To determine and quantify vinblastine in different varieties of Catharanthus roseus using reversed-phase HPLC method. Methods: The liquid chromatographic separation was performed using a reversed phase C18, Microsorb - MV column (250 mm x 4.6 mm, 5 µm) at room temperature and eluted with a mobile phase containing methanol – phosphate buffer (5 mM, pH 6.0) – acetonitrile with different proportion gradient elution at a flow rate of 2.0 mL min-1 and detection at 254 nm. Results: The HPLC method was utilized for the quantification of vinblastine in purple, red and white varieties of Catharanthus roseus leaves. The separation was achieved in less than 8 min. The peak confirmation was done based on the retention times and UV spectra of the reference substance. The method was validated with respect to linearity, precision, recovery, limit of detection and quantification. Results showed that the purple variety gives 1.2 and 1.5 times more vinblastine concentration compared to the white and pink varieties, respectively. Conclusion: The obtained results from different varieties are thus useful for the purpose of vinblastine production from Catharanthus roseus plant.


Verified
Journal Article
Open access
PDF file
MMMohd Maaruf Abdul Malik
Mohd Maaruf Abdul Malik
ASAhmad Nazrun Shuid
Ahmad Nazrun Shuid
NRNurul Raudzah Adib RAUDZAH ADIB Ridzuan
Nurul Raudzah Adib RAUDZAH ADIB Ridzuan
INIsa Naina-Mohamed
Isa Naina-Mohamed
ERElvy Suhana Mohd Ramli
Elvy Suhana Mohd Ramli
RRRohanizah Abdul Rahim
Rohanizah Abdul Rahim
The genus Acmella has received growing attention for its pharmacological properties, including its potential applications in musculoskeletal disorders (MSDs). Plants in this genus, such as Spilanthes acmella, Blainvillea acmella, Acmella uliginosa, and Acmella oleracea contain various bioactive compounds which have demonstrated anti-inflammatory, analgesic, and anti-arthritic properties. This systematic review evaluates the clinical and preclinical evidence supporting the use of plants from Acmella genus for the treatment of MSD, such as arthritis, osteoporosis, muscle injuries, joint inflammation, and other related pathologies. The methodology used in this study involved a systematic literature review, following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, along with synthesis analysis and quality appraisal. The articles were retrieved from Scopus, Google Scholar, and PubMed databases. Eleven articles were further analyzed to determine the therapeutic potential of Acmella genus plants for musculoskeletal disorders. The plants included were Spilanthes acmella, Blainvillea acmella, Acmella uliginosa, and Acmella olerecia. The musculoskeletal disorders investigated were osteoporosis, osteoarthritis, and myopathies. The extracts from these plants were shown to decrease inflammation, enhance joint health, relieve pain, and stimulate osteogenic activity. These effects may be attributed to several active compounds found in these plants. The available evidence suggests that Spilanthes acmella and Blainvillea acmella have the potential to treat osteoporosis. Acmella oleracea and Acmella uliginosa have the potential to be used for the treatment of osteoarthritis, while Spilanthes acmella is used to treat myopathies. Further research is needed to establish the efficacy, optimal dosing, and safety of these plants.

4 June 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MMMohd Maaruf Abdul Malik
Mohd Maaruf Abdul Malik
ASAhmad Nazrun Shuid
Ahmad Nazrun Shuid
NRNurul Raudzah Adib RAUDZAH ADIB Ridzuan
Nurul Raudzah Adib RAUDZAH ADIB Ridzuan
INIsa Naina-Mohamed
Isa Naina-Mohamed
ERElvy Suhana Mohd Ramli
Elvy Suhana Mohd Ramli
RRRohanizah Abdul Rahim
Rohanizah Abdul Rahim
Background: The genus Acmella has received growing attention for its pharmacological properties, including its potential applications in musculoskeletal disorders (MSD). Plants in this genus such as Spilanthes acmella, Blainvillea acmella, Acmella uliginosa and Acmella oleracea contain various bioactive compounds which have demonstrated anti-inflammatory, analgesic, and anti-arthritic properties. This systematic review evaluates the clinical and preclinical evidence supporting the use of plants from Acmella genus for treatment of MSD such as arthritis, osteoporosis, muscle injuries, joint inflammation, and other related pathologies. Methods: The methodology used in this study involved a systematic literature review, following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, along with synthesis analysis and quality appraisal. The articles were retrieved from Scopus, Google Scholar and PubMed databases. Results: Eleven articles were further analysed to determine the therapeutic potential of Acmella genus plants for musculosketelal disorders. The plants included were Spilanthes acmella, Blainvillea acmella, Acmella uliginosa, and Acmella olerecia. The musculoskeletal disorders investigated were osteoporosis, osteoarthritis and myopathies. The extracts from these plants were shown to decrease inflammation, enhance joint health, relieve pain, and stimulate osteogenic activity. These effects may be contributed with several active compounds found in these plants. Conclusions: The available evidence suggests that Spilanthes acmella and Blainvillea acmella have potential to treat osteoporosis. Acmella oleracea and Acmella uliginosa have potential to be used for treatment of osteoarthritis while Spilanthes acmella in treating myopathies. Further research is needed to establish efficacy, optimal dosing, and safety of these plants.